The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1

被引：28
作者：
Jenal, M. [1 ]
Batliner, J. [1 ]
Reddy, V. A. [2 ]
Haferlach, T. [3 ]
Tobler, A. [1 ,4 ]
Fey, M. F. [5 ]
Torbett, B. E. [6 ]
Tschan, M. P. [1 ,5 ]
机构：
[1] Univ Bern, Dept Clin Res, Bern, Switzerland
[2] Novartis Inst Funct Genom, Canc Stem Cell Program, San Diego, CA USA
[3] MLL Munich Leukemia Lab, Munich, Germany
[4] Univ Hosp Bern, Inselspital, Dept Hematol, CH-3010 Bern, Switzerland
[5] Univ Hosp Bern, Inselspital, Dept Med Oncol, CH-3010 Bern, Switzerland
[6] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
来源：
LEUKEMIA | 2010年 / 24卷 / 05期
关键词：
LEUKEMIC-CELLS; DIFFERENTIATION; BCL-2; DEATH; A1; EXPRESSION; BFL-1/A1; FAMILY; TRAIL; ETS2;
D O I：
10.1038/leu.2010.26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1073 / 1076
页数：5
相关论文
共 19 条
  • [1] Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
    Altucci, L
    Rossin, A
    Raffelsberger, W
    Reitmair, A
    Chomienne, C
    Gronemeyer, H
    [J]. NATURE MEDICINE, 2001, 7 (06) : 680 - 686
  • [2] PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45
    Anderson, KL
    Nelson, SL
    Perkin, HB
    Smith, KA
    Klemsz, MJ
    Torbett, BE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) : 7637 - 7642
  • [3] Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene
    Hamasaki, A
    Sendo, F
    Nakayama, K
    Ishida, N
    Negishi, I
    Nakayama, K
    Hatakeyama, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 1985 - 1992
  • [4] LIN EY, 1993, J IMMUNOL, V151, P1979
  • [5] Cytoprotective response of A1, a Bcl-2 homologue expressed in mature human neutrophils and promyelocytic HL-60 cells, to oxidant stress-induced cell death
    Liu, CY
    Chuang, PI
    Chou, CL
    Lin, SM
    Chen, HC
    Chou, P
    Liu, YH
    Yu, CT
    Wang, CH
    Lin, HC
    Kuo, HP
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2004, 11 (02) : 214 - 227
  • [6] ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression
    Mueller, BU
    Pabst, T
    Fos, J
    Petkovic, V
    Fey, MF
    Asou, N
    Buergi, U
    Tenen, DG
    [J]. BLOOD, 2006, 107 (08) : 3330 - 3338
  • [7] Potential autoregulation of transcription factor PU.1 by an upstream reaulatory element
    Okuno, Y
    Huang, G
    Rosenbauer, F
    Evans, EK
    Radomska, HS
    Iwasaki, H
    Akashi, K
    Moreau-Gachelin, F
    Li, YL
    Zhang, P
    Göttgens, B
    Tenen, DG
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (07) : 2832 - 2845
  • [8] Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation
    Rimmele, Pauline
    Kosmider, Olivier
    Mayeux, Patrick
    Moreau-Gachelin, Francoise
    Guillouf, Christel
    [J]. BLOOD, 2007, 109 (07) : 3007 - 3014
  • [9] Transcription factors in myeloid development: balancing differentiation with transformation
    Rosenbauer, Frank
    Tenen, Daniel G.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2007, 7 (02) : 105 - 117
  • [10] Bcl-xL expression correlates with primary macrophage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1
    Sevilla, L
    Zaldumbide, A
    Carlotti, F
    Dayem, MA
    Pognonec, P
    Boulukos, KE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 17800 - 17807
12